Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial
Saved in:
| Published in | American journal of kidney diseases Vol. 74; no. 5; pp. 713 - 715 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.11.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0272-6386 1523-6838 1523-6838 |
| DOI | 10.1053/j.ajkd.2019.03.432 |
Cover
| Author | Wanner, Christoph Koitka-Weber, Audrey Inzucchi, Silvio E. von Eynatten, Maximilian Cooper, Mark E. Zinman, Bernard Hantel, Stefan |
|---|---|
| Author_xml | – sequence: 1 givenname: Mark E. surname: Cooper fullname: Cooper, Mark E. email: mark.cooper@monash.edu organization: Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia – sequence: 2 givenname: Silvio E. surname: Inzucchi fullname: Inzucchi, Silvio E. organization: Section of Endocrinology, Yale School of Medicine, New Haven, CT – sequence: 3 givenname: Bernard surname: Zinman fullname: Zinman, Bernard organization: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada – sequence: 4 givenname: Stefan surname: Hantel fullname: Hantel, Stefan organization: Boehringer Ingelheim International GmbH, Biberach – sequence: 5 givenname: Maximilian surname: von Eynatten fullname: von Eynatten, Maximilian organization: Boehringer Ingelheim International GmbH, Ingelheim – sequence: 6 givenname: Christoph surname: Wanner fullname: Wanner, Christoph organization: Department of Medicine, Würzburg University Clinic, Würzburg, Germany – sequence: 7 givenname: Audrey surname: Koitka-Weber fullname: Koitka-Weber, Audrey organization: Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31255334$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU1v1DAQhi1URLctf4AD8pFLgr-SzVZcVku6VLTaCm3PlmNPwFvHXuwEKRz55WS1LYceijTSSKPnmcP7nqETHzwg9I6SnJKCf9zlavdgckboIic8F5y9QjNaMJ6VFa9O0IywOctKXpWn6CylHSFkwcvyDTrllBUF52KG_qzdoEMCvAq-j8Fh5Q3ufwCu2xZ0j0OL626vvjvbuvDbehw8_mqNhxFvhl6HDhKerttxD5jhz1Y10EO6xEs_jXJjsglfxdAdf97eLbNv9Rpv7rerzW2Nt9Eqd4Fet8olePu4z9H9Vb1dfcluNuvr1fIm04LM-4yX0FDOWto0wnBtaLEQghBoecOJJsIs9JwYqAxorgRrdVXqQoEogApoVMPP0Yfj330MPwdIvexs0uCc8hCGJBkrSMkE4WJC3z-iQ9OBkftoOxVH-ZTbBLAjoGNIKUL7D6FEHsqRO3koRx7KkYTLqZxJqp5J2vaqt4fklXUvq5-OKkwB_bIQZdIWvAZj41STNMG-rF8-07Wz3mrlHmD8n_wXhva8hg |
| CitedBy_id | crossref_primary_10_1016_j_diabres_2021_109036 crossref_primary_10_2337_dc21_1744 crossref_primary_10_1186_s12933_022_01575_9 crossref_primary_10_1016_j_kint_2020_10_031 crossref_primary_10_1016_j_mmm_2020_04_014 crossref_primary_10_1111_dom_13965 crossref_primary_10_1038_s41574_020_0392_2 crossref_primary_10_1007_s11255_023_03586_1 crossref_primary_10_1111_dom_13945 crossref_primary_10_1007_s43440_022_00442_4 crossref_primary_10_1016_j_tem_2021_02_007 crossref_primary_10_1080_14740338_2020_1733967 crossref_primary_10_1016_j_jacc_2019_11_031 crossref_primary_10_3803_EnM_2021_987 crossref_primary_10_1590_2175_8239_jbn_2020_0100 crossref_primary_10_1111_imj_16203 crossref_primary_10_1111_dom_14513 crossref_primary_10_1111_dom_14535 crossref_primary_10_1016_j_medj_2021_10_004 crossref_primary_10_1097_MNH_0000000000000724 crossref_primary_10_1007_s40200_024_01545_w crossref_primary_10_1007_s40264_020_01010_6 crossref_primary_10_1016_j_diabet_2019_10_006 crossref_primary_10_1016_j_diabres_2021_108831 crossref_primary_10_1007_s10741_020_10024_2 crossref_primary_10_1093_ndt_gfab176 crossref_primary_10_1016_j_diabet_2021_101285 crossref_primary_10_1186_s12933_021_01358_8 crossref_primary_10_1093_ndt_gfz230 crossref_primary_10_1093_ndt_gfz252 crossref_primary_10_3389_fphar_2021_761855 crossref_primary_10_1002_14651858_CD015588_pub2 crossref_primary_10_2215_CJN_14901219 crossref_primary_10_1001_jamacardio_2020_4511 |
| Cites_doi | 10.1038/nrneph.2013.251 10.1038/ki.2014.128 10.1056/NEJMoa1504720 10.1681/ASN.2012070718 10.1016/S2213-8587(17)30182-1 10.1001/jama.2016.10924 10.1056/NEJMoa1515920 10.1681/ASN.2016030278 |
| ContentType | Journal Article |
| Copyright | 2019 National Kidney Foundation, Inc. |
| Copyright_xml | – notice: 2019 National Kidney Foundation, Inc. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1053/j.ajkd.2019.03.432 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1523-6838 |
| EndPage | 715 |
| ExternalDocumentID | 31255334 10_1053_j_ajkd_2019_03_432 S0272638619307358 |
| Genre | Letter Research Support, Non-U.S. Gov't |
| GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 1B1 1P~ 23M 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 AAEDT AAEDW AAFWJ AALRI AAQFI AAQQT AAQXK AAWTL AAXUO AAYWO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO ADVLN AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGHFR AGQPQ AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BELOY CAG COF CS3 EBS EFJIC EFKBS EJD EX3 F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ J5H K-O KOM L7B M41 MO0 N4W O9- OE- P2P PC. PI~ R2- ROL SEL SES SJN SSZ TWZ UNMZH WOW X7M XH2 YCW Z5R ZGI ZXP AAIAV AAYOK ADPAM AFCTW AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c407t-36eb132f1bb4d3cd1594400ef3b30c04d9c70de8dec3a42fc86c5ae45e14ebab3 |
| ISSN | 0272-6386 1523-6838 |
| IngestDate | Sun Sep 28 10:50:44 EDT 2025 Thu Jan 02 22:59:02 EST 2025 Thu Apr 24 23:04:13 EDT 2025 Tue Jul 01 01:33:48 EDT 2025 Fri Feb 23 02:28:34 EST 2024 Tue Aug 26 16:58:39 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c407t-36eb132f1bb4d3cd1594400ef3b30c04d9c70de8dec3a42fc86c5ae45e14ebab3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23 |
| PMID | 31255334 |
| PQID | 2250624034 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | proquest_miscellaneous_2250624034 pubmed_primary_31255334 crossref_primary_10_1053_j_ajkd_2019_03_432 crossref_citationtrail_10_1053_j_ajkd_2019_03_432 elsevier_sciencedirect_doi_10_1053_j_ajkd_2019_03_432 elsevier_clinicalkey_doi_10_1053_j_ajkd_2019_03_432 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | November 2019 2019-11-00 20191101 |
| PublicationDateYYYYMMDD | 2019-11-01 |
| PublicationDate_xml | – month: 11 year: 2019 text: November 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | American journal of kidney diseases |
| PublicationTitleAlternate | Am J Kidney Dis |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Cherney, Zinman, Inzucchi (bib8) 2017; 5 Wanner, Inzucchi, Lachin (bib6) 2016; 375 Heerspink, Desai, Jardine, Balis, Meininger, Perkovic (bib7) 2017; 28 Zinman, Wanner, Lachin (bib5) 2015; 373 Molitch, Adler, Flyvbjerg (bib3) 2015; 87 Roscioni, Heerspink, de Zeeuw (bib4) 2014; 10 Afkarian, Zelnick, Hall (bib1) 2016; 316 Afkarian, Sachs, Kestenbaum (bib2) 2013; 24 Molitch (10.1053/j.ajkd.2019.03.432_bib3) 2015; 87 Wanner (10.1053/j.ajkd.2019.03.432_bib6) 2016; 375 Afkarian (10.1053/j.ajkd.2019.03.432_bib1) 2016; 316 Roscioni (10.1053/j.ajkd.2019.03.432_bib4) 2014; 10 Cherney (10.1053/j.ajkd.2019.03.432_bib8) 2017; 5 Heerspink (10.1053/j.ajkd.2019.03.432_bib7) 2017; 28 Afkarian (10.1053/j.ajkd.2019.03.432_bib2) 2013; 24 Zinman (10.1053/j.ajkd.2019.03.432_bib5) 2015; 373 |
| References_xml | – volume: 373 start-page: 2117 year: 2015 end-page: 2128 ident: bib5 article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes publication-title: N Engl J Med – volume: 28 start-page: 368 year: 2017 end-page: 375 ident: bib7 article-title: Canagliflozin slows progression of renal function decline independently of glycemic effects publication-title: J Am Soc Nephrol – volume: 10 start-page: 77 year: 2014 end-page: 87 ident: bib4 article-title: The effect of RAAS blockade on the progression of diabetic nephropathy publication-title: Nat Rev Nephrol – volume: 24 start-page: 302 year: 2013 end-page: 308 ident: bib2 article-title: Kidney disease and increased mortality risk in type 2 diabetes publication-title: J Am Soc Nephrol – volume: 316 start-page: 602 year: 2016 end-page: 610 ident: bib1 article-title: Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014 publication-title: JAMA – volume: 5 start-page: 610 year: 2017 end-page: 621 ident: bib8 article-title: Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial publication-title: Lancet Diabetes Endocrinol – volume: 375 start-page: 323 year: 2016 end-page: 334 ident: bib6 article-title: Empagliflozin and progression of kidney disease in type 2 diabetes publication-title: N Engl J Med – volume: 87 start-page: 20 year: 2015 end-page: 30 ident: bib3 article-title: Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes publication-title: Kidney Int – volume: 10 start-page: 77 issue: 2 year: 2014 ident: 10.1053/j.ajkd.2019.03.432_bib4 article-title: The effect of RAAS blockade on the progression of diabetic nephropathy publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2013.251 – volume: 87 start-page: 20 issue: 1 year: 2015 ident: 10.1053/j.ajkd.2019.03.432_bib3 article-title: Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes publication-title: Kidney Int doi: 10.1038/ki.2014.128 – volume: 373 start-page: 2117 issue: 22 year: 2015 ident: 10.1053/j.ajkd.2019.03.432_bib5 article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1504720 – volume: 24 start-page: 302 issue: 2 year: 2013 ident: 10.1053/j.ajkd.2019.03.432_bib2 article-title: Kidney disease and increased mortality risk in type 2 diabetes publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012070718 – volume: 5 start-page: 610 issue: 8 year: 2017 ident: 10.1053/j.ajkd.2019.03.432_bib8 article-title: Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30182-1 – volume: 316 start-page: 602 issue: 6 year: 2016 ident: 10.1053/j.ajkd.2019.03.432_bib1 article-title: Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014 publication-title: JAMA doi: 10.1001/jama.2016.10924 – volume: 375 start-page: 323 issue: 4 year: 2016 ident: 10.1053/j.ajkd.2019.03.432_bib6 article-title: Empagliflozin and progression of kidney disease in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1515920 – volume: 28 start-page: 368 issue: 1 year: 2017 ident: 10.1053/j.ajkd.2019.03.432_bib7 article-title: Canagliflozin slows progression of renal function decline independently of glycemic effects publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2016030278 |
| SSID | ssj0009366 |
| Score | 2.4791546 |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 713 |
| SubjectTerms | Benzhydryl Compounds - administration & dosage Blood Glucose - metabolism Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetic Nephropathies - epidemiology Diabetic Nephropathies - etiology Diabetic Nephropathies - prevention & control Dose-Response Relationship, Drug Global Health Glucosides - administration & dosage Humans Prevalence Randomized Controlled Trials as Topic Risk Factors Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Treatment Outcome |
| Title | Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0272638619307358 https://dx.doi.org/10.1053/j.ajkd.2019.03.432 https://www.ncbi.nlm.nih.gov/pubmed/31255334 https://www.proquest.com/docview/2250624034 |
| Volume | 74 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1523-6838 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009366 issn: 0272-6386 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyFeEHfKTUbiLUpJYidpeOuqrhNQiliLJl6i2E5QtiqZtpaHPvJ7-JEcxydpqrEBe4kqp47dni8-F5_vmJA3WSCkAv8f3JIo0kW1U1vwKLClr9hASs9nieY7Tz8Fhwv-_tg_7nR-tbKW1ivRl5s_8kpuIlVoA7lqlux_SLZ5KDTAZ5AvXEHCcP0nGU8w33yE-eZ1NiSWJNZJg_C2f1_m2bLc5IXeGPiQqwKWgdl6BROqkrGsuYnCYm7MBYYKm2olBzUBZTz9PLS_jCfWbDEfzaZja65_Ytu6bbZ_WvUoTs2AuBHUWPCjsjwzaNFsIWvcbzBabNZSVkcNW0f58kdetm5-ywuM2O7rOOa52i6gmg6DaWsZIh6DGW6ErL4mwlazbHaSQMFz9mxYJ4L2qm3O9kF0-q0lODTcVtTmoSGLXlIUTnXax0k_OTnV9WLdqtQtx1DrbgHuIz2-Hh5sXVgQ_cEtsueFQeB1yd5k_-PX4bbIMzN74_V8kaQFY729PNJVhtBVjk5l8MzvkbvoqdChgd190kmLB-T2FHMxHpKfiD6K6KOAPgo4oQZ9tMzoDvpoWVCDPlqjj0KrRh_1aI2-d3RY0Bp7VGPPPBOxRxF7tMLeI7I4GM9Hhzae6GFL7oQrmwVgGjAvc4XgikkFtjQHJZJmTDBHOlxFMnRUOlCpZAn3MjkIpJ-k3E9dnopEsMekW5RF-pRQJhRzRcACEUVcCJFIJYUrMyUHSpfD7xG3_ntjieXu9akry7hKu_AZuL1aJLEWSeywGETSI1bT58wUe7n226yWWlzTmEHxxgCxa3v5TS80co3x-td-r2tgxKAB9LZeUqTl-iIGjewEuqwm75EnBjHN7Bn4L5ps_-xGc31O7mxf0hekuzpfpy_BBl-JVwj938yC2z0 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glucose+Control+and+the+Effect+of+Empagliflozin+on+Kidney+Outcomes+in+Type+2+Diabetes%3A+An+Analysis+From+the+EMPA-REG+OUTCOME+Trial&rft.jtitle=American+journal+of+kidney+diseases&rft.au=Cooper%2C+Mark+E.&rft.au=Inzucchi%2C+Silvio+E.&rft.au=Zinman%2C+Bernard&rft.au=Hantel%2C+Stefan&rft.date=2019-11-01&rft.pub=Elsevier+Inc&rft.issn=0272-6386&rft.volume=74&rft.issue=5&rft.spage=713&rft.epage=715&rft_id=info:doi/10.1053%2Fj.ajkd.2019.03.432&rft.externalDocID=S0272638619307358 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0272-6386&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0272-6386&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0272-6386&client=summon |